Kathleen E Rodgers (K E Rodgers)

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 2

Top Topics

Radical Prostatectomy

Prostate Cancer

Skeletal Muscle

Top Venues

European journal of haematology

Cancer medicine

This page only lists publications with an associated author ORCID identifier.

Publications

P Namsolleck, Kathleen E Rodgers, R Franklin, Gert N Moll
LP2, a stable lanthipeptide derived from cAng-(1-7), exerts myeloprotective action in mice. European journal of haematology (2023)
Gregory L Branigan, Georgina Torrandell-Haro, Maira Soto, Edward P Gelmann, Francesca Vitali, Kathleen E Rodgers, Roberta Diaz Brinton
Androgen-targeting therapeutics mitigate the adverse effect of GnRH agonist on the risk of neurodegenerative disease in men treated for prostate cancer. Cancer medicine 11 (13) (2022)